. Author manuscript; available in PMC: 2018 Sep 1.

Published in final edited form as: Depress Anxiety. 2017 Sep 29;34(12):1147–1156. doi: 10.1002/da.22681

Appendix Table 3.

Predicted Changes in Rates and Slopes in Antidepressant Prescription Fills Among Those Receiving Treatment for Depression and After FDA Boxed Warning, by Race/Ethnicity (n=249)

	White	Black		Latino
	Estimate (SE)	Estimate (SE)	Different from White	Estimate (SE)	Different from White

Baseline Jan 2002 Rate^†	3445.20 (86.20)	1844.81 (68.10)	^***	1848.30 (63.01)	^***

Change in rate after warning^Δ	−731.98 (146.81)^***	−614.44 (116.88)^***	ns	−665.91 (108.52)^***	ns

Slope (Δ/month) before warning^‡	19.86 (6.35)^**	28.76 (5.03)^***	ns	23.59 (4.66)^***	ns

Slope (Δ/month) after warning^‡	−7.84 (1.46)^***	−11.93 (1.15)^***	^***	−7.40 (1.06)^***	ns

Change in slope	−27.70 (6.75)^***	−40.68 (5.33)^***	^*	−30.99 (4.93)^***	ns

p<0.05,

^**

p<0.01,

^***

p<0.001

^†

Rate is number of prescription fills/10,000 youth with a diagnosis of depressive disorder per month

^‡

Slope is monthly change in number of prescription fills/10,000 youth

^Δ

Change in rate is level shift between October 2003 and October 2004